2023
Unlocking the Proteome - The NULISA™ Platform
Entrant Company
Halteres Associates
Category
Video, Commercial & Film - Animation
Client's Name
Alamar Biosciences
Country / Region
United States
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
The Next Practice
Category
Website - Science / Technology
Country / Region
United States
Entrant Company
Iris GmbH
Category
Video, Commercial & Film - Branding
Country / Region
Germany
Entrant Company
Get Well
Category
Provider & Services - Patient Engagement
Country / Region
United States
Entrant Company
MI Health Agency
Category
Video, Commercial & Film - Public Service & Activism
Country / Region
Ukraine